Trade Name | KYORIN Pharmaceutical Co., Ltd. |
---|---|
Main Business | Manufacture, sale and purchases of prescription medicines |
Location of Head Quarter | 1-3-7, Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan |
Telephone | 03-6374-9700 |
Founding | 1923 |
Paid-in Capital | 700 million yen |
Listing | Tokyo Stock Exchange |
Board of Directors and Corporate Auditors
Representative Director, President and Chief Executive Officer |
Yutaka Ogihara |
---|---|
Executive Director, CMO President of KYORIN Pharmaceutical Group Facilities Co., Ltd. |
Michiro Onota |
Executive Director CFO & CStO, Director of Corporate Planning |
Yasuji Kurose |
Executive Director(outside) | Noriyuki Shikanai Ken Shigematsu Hiromi Watanabe |
Audit & Supervisory Board Member | Tomiharu Matsumoto Kenji Akutsu |
Audit & Supervisory Board Member (outside) | Takao Yamaguchi Yukio Ikemura Kensuke Morita |
Corporate Officer
Corporate Officer CBDO, Senior Director of Business Development HQs |
Takaaki Kaji |
---|---|
Corporate Officer CCO, Senior Director of Sales & Marketing HQs |
Noriaki Tamura |
Corporate Officer CSO, Senior Director of Discovery Research HQs |
Junichi Ishiyama |
Corporate Officer CHRO, Director of General Affairs |
Kiyoo Uehara |
Senior Corporate Officer, Senior Director of SCM HQs |
Kei Takahashi |
Corporate Officer, President of KYORIN Rimedio Co., Ltd. |
Hiroshi Hashizume |
Corporate Officer, Deputy Senior Director of Business Development HQs |
Makoto Yanai |
Corporate Officer, Senior Director of Quality Assurance & Reliability HQs |
Katsuhiro Hamada |
Corporate Officer, Executive Director and Vice President of KYORIN Rimedio Co., Ltd. |
Kenichi Nakamura |
Corporate Officer, Director of Product Strategy |
Kimiya Masada |